Option Care Health, Inc. (NASDAQ:OPCH) Shares Bought by Deutsche Bank AG

Deutsche Bank AG raised its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 8.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 637,305 shares of the company's stock after acquiring an additional 50,149 shares during the quarter. Deutsche Bank AG owned approximately 0.37% of Option Care Health worth $14,785,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Cornerstone Investment Partners LLC grew its position in shares of Option Care Health by 3.6% during the fourth quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock worth $221,000 after buying an additional 333 shares in the last quarter. UMB Bank n.a. grew its position in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after buying an additional 346 shares in the last quarter. Assetmark Inc. grew its position in shares of Option Care Health by 2.0% during the fourth quarter. Assetmark Inc. now owns 24,976 shares of the company's stock worth $579,000 after buying an additional 487 shares in the last quarter. Pacer Advisors Inc. grew its position in shares of Option Care Health by 2.2% during the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock worth $591,000 after buying an additional 537 shares in the last quarter. Finally, Sheets Smith Wealth Management grew its position in shares of Option Care Health by 2.4% during the fourth quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company's stock worth $553,000 after buying an additional 550 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.64% of the stock is owned by company insiders.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $32.49 on Friday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The stock has a 50 day moving average of $33.07 and a two-hundred day moving average of $28.96. The stock has a market cap of $5.32 billion, a P/E ratio of 27.30, a P/E/G ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. During the same quarter in the previous year, the business earned $0.26 earnings per share. The firm's revenue for the quarter was up 16.3% on a year-over-year basis. On average, research analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on OPCH shares. Barrington Research reissued an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Wednesday, April 30th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a report on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. upped their price target on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $35.50.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.